AB0226 Predictors of response after cessation of JAKi therapy in patients with RA

De Cock, Diederik;Durez, Patrick;Lenaerts, Jan;Westhovens, René;Verschueren, Patrick
(2023) EULAR 2023 European Congress of Rheumatology — Location: (Italy) Milano (31.May.2023)

Files

2023_EULAR_AB0226.pdf
  • Open Access
  • Adobe PDF
  • 267.21 KB
Download

Details

Authors
  • De Cock, Diederik
    Author
  • Durez, PatrickUCLouvain
    Author
  • Lenaerts, Jan
    Author
  • Westhovens, René
    Author
  • Verschueren, Patrick
    Author
Abstract
BACKGROUND: In a previous study based on data from the Belgian register “Tool for Administrative Reimbursement Drug Information Sharing” (TARDIS)[1], IL6 inhibitors showed a better clinical response after JAKi cessation compared to other b/tsDMARDs. However, considerable baseline differences in demographic and clinical variables, and previous exposure to advanced therapies were found between treatment groups, which could have influenced our results. OBJECTIVES: We aimed to find predictors of short-term response after cessation of JAKi therapy in patients with RA. :[…]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

De Cock, D., Durez, P., Lenaerts, J., Westhovens, R., & Verschueren, P. (2023). AB0226 Predictors of response after cessation of JAKi therapy in patients with RA. Annals of the rheumatic diseases, 82(Suppl 1), 1297. https://doi.org/10.1136/annrheumdis-2023-eular.3713 (Original work published 2023)